Aspen Pharmacare Current Ratio 2017-2023 | APNHY
Aspen Pharmacare current ratio from 2017 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aspen Pharmacare Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2023-06-30 |
$2.51B |
$1.31B |
1.92 |
2022-12-31 |
$2.25B |
$0.94B |
2.40 |
2022-06-30 |
$2.27B |
$1.54B |
1.48 |
2021-12-31 |
$2.37B |
$1.21B |
1.96 |
2021-06-30 |
$2.13B |
$2.40B |
0.89 |
2020-12-31 |
$2.79B |
$1.29B |
2.16 |
2020-06-30 |
$2.37B |
$1.16B |
2.03 |
2019-06-30 |
$2.55B |
$1.41B |
1.80 |
2018-12-31 |
$3.17B |
$1.55B |
2.05 |
2018-06-30 |
$3.14B |
$2.20B |
1.43 |
2017-12-31 |
$2.65B |
$2.97B |
0.89 |
2017-06-30 |
$2.80B |
$2.56B |
1.10 |
2016-12-31 |
$2.61B |
$1.76B |
1.48 |
2016-06-30 |
$2.58B |
$1.46B |
1.76 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$4.985B |
$2.296B |
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|